"Macula Lutea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)
Concept/Terms
Macula Lutea- Macula Lutea
- Lutea, Macula
- Luteas, Macula
- Macula Luteas
Below are MeSH descriptors whose meaning is more general than "Macula Lutea".
Below are MeSH descriptors whose meaning is more specific than "Macula Lutea".
This graph shows the total number of publications written about "Macula Lutea" by people in Harvard Catalyst Profiles by year, and whether "Macula Lutea" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 1 | 4 |
| 1999 | 4 | 1 | 5 |
| 2000 | 0 | 1 | 1 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 1 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 1 | 4 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 0 | 3 |
| 2010 | 4 | 0 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 2 | 5 |
| 2017 | 2 | 3 | 5 |
| 2018 | 6 | 2 | 8 |
| 2019 | 6 | 3 | 9 |
| 2020 | 3 | 1 | 4 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 1 | 2 |
Below are the most recent publications written about "Macula Lutea" by people in Profiles.
-
Application of Optical Coherence Tomography Angiography Macular Analysis for Systemic Hypertension. A Systematic Review and Meta-analysis. Am J Hypertens. 2022 04 02; 35(4):356-364.
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet. 2022 02 19; 399(10326):741-755.
-
Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept. Front Immunol. 2021; 12:738521.
-
Multimodal imaging of type 2 acute macular neuroretinopathy in a young woman. Digit J Ophthalmol. 2021; 27(3):44-47.
-
Juxtapapillary Choroidal Neovascular Membrane as a Complication of Optic Disc Drusen: Multimodal Imaging With Swept Source-Optical Coherence Tomography and Optical Coherence Tomography Angiography. J Neuroophthalmol. 2022 03 01; 42(1):e430-e433.
-
Contrast sensitivity function in patients with macular disease and good visual acuity. Br J Ophthalmol. 2022 06; 106(6):839-844.
-
Association of OCT Angiography Parameters With Age in Cognitively Healthy Older Adults. Ophthalmic Surg Lasers Imaging Retina. 2020 12 01; 51(12):706-714.
-
Surgical Outcomes of Primary RRD With and Without Concurrent Full-Thickness Macular Hole (PRO Study Report No. 7). Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):500-505.
-
Lutein Supplementation for Eye Diseases. Nutrients. 2020 Jun 09; 12(6).
-
Resolution of optic disc pit-associated macular retinoschisis after topical carbonic anhydrase inhibitor treatment: Report of a case. Eur J Ophthalmol. 2021 May; 31(3):NP25-NP28.